Inactive Instrument

Avisa Diagnostics Inc. Canadian Securities Exchange

MKU.H

CA05380J1075

Biotechnology & Medical Research

Avisa Diagnostics Inc. announced that it has received CAD 0.1264 million in funding

August 24, 2021

On August 25, 2021, Avisa Diagnostics Inc. closed the transaction.

Latest news about Avisa Diagnostics Inc.

Avisa Diagnostics Inc. is a clinical-stage medical device company. The Company is engaged in the development of the Allora BreathTest (ABT), a drug/device biomarker technology platform. The Allora BreathTest (ABT) is an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of bacterial load. ABT enables the ultra-rapid detection of virulent bacterial pathogens, detecting and monitoring bacterial load after the patient inhales or ingests its drug substrates via its own delivery systems. Its ABT portfolio includes Post-Covid-19 Bronchiectasis, Develo, Ventilator-Associated Pneumonia (VAP), Chronic Obstructive Pulmonary Disease (COPD), Community-Acquired, Pneumonia (CAP), Cystic Fibrosis, Tuberculosis, Aspergillus Fungus and Clostridium Difficile (C. diff).

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	+3.13%	43.43B
LONZA GROUP AG	+48.94%	41.69B
MODERNA, INC.	+8.49%	41.31B
CELLTRION, INC.	-10.82%	27.14B
ICON PUBLIC LIMITED COMPANY	+8.26%	25.28B
ALNYLAM PHARMACEUTICALS, INC.	-23.69%	18.47B
MEDPACE HOLDINGS, INC.	+32.83%	12.59B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+1.58%	12.33B
UNITED THERAPEUTICS CORPORATION	+6.63%	11.03B

Other Biotechnology & Medical Research

Avisa Diagnostics Inc. Canadian Securities Exchange

Equities

MKU.H

CA05380J1075

Biotechnology & Medical Research

Avisa Diagnostics Inc. announced that it has received CAD 0.1264 million in funding

Latest news about Avisa Diagnostics Inc.

Chart Avisa Diagnostics Inc.

Company Profile

Sector Other Biotechnology & Medical Research